previous approval shall end on the date when the latter approval takes effect; (b) in other cases apart from sub clause (a), the period of approval of all types shall cease on the expired date of the latest

rate of 12 percent per annum, aggregating USD 24,600,000, or equivalent to THB 848,926,866.67. However, the interest amount may be reduced in the case of partial principal prepayment. (2) Front end fee

resolved to declare total dividends for the year 2017 at Baht 0.03 per share, totaling Baht 12 Million and was paid on 25 April 2018. 2 At the end of March 31, 2018, the total assets were increased 54.43

sales promotion expenses. The company had no financial cost. In 2019, the company had tax expense 37 Million Baht from the profit increasing. 2 At the end of December 31, 2019, the total assets 2,260

6.3 Million Baht due to increased profits. At the end of June 30, 2019, the total asset 2,216.9 Million Baht were increased 129.9 Million Baht compare with at the end of December 31, 2018 increasing

expenses of 9.7 Million Baht due to increased profits. At the end of September 30, 2019, the total assets 2,262.6 Million Baht were increased 175.7 Million Baht compare with at the end of December 31, 2018

2019, compared with last year were decreased 1.8 Million Baht or 4% mainly due to transportation costs. In 2020, the company had tax expense 13.7 Million Baht from higher profit. 2 At the end of March 31

Finance Costs were 0.3 Million Baht from Interest expense on lease liabilities. The company has income tax expense of 10.0 Million Baht due to increased profits. 2 At the end of June 30, 2020 the total

The Stock Exchange of Thailand The operating performance for three-month period end 30 September 2019 of Mahachai Hospital Public Company Limited compared to the prior year was increasing in net profit

Attn : The Directors and The MAI Manager Ref: Dimet AC 0817/1 August 30, 2017 Attention: The Directors and The MAI Manager The Stock Exchange of Thailand Subject: Year End result and clarification of